Is fluconazole (Diflucan) safe during breastfeeding?

Fluconazole (Diflucan) is Compatible with Breastfeeding

Fluconazole is safe to use during breastfeeding, with no need to interrupt nursing. The amount of fluconazole that enters breast milk is less than the standard neonatal dosage, and no problems have been documented in breastfed infants whose mothers received oral fluconazole 1.

Key Safety Evidence

Guideline Recommendations

The 2020 ERS/TSANZ Task Force explicitly classifies fluconazole as "Compatible" for breastfeeding 1. The guidelines note that:

• Fluconazole is present in breast milk but at levels below neonatal therapeutic doses 1
• No problems have been observed in breastfed infants from mothers treated with oral fluconazole 1

The 2016 IDSA guidelines for coccidioidomycosis specifically state that breastfeeding is not recommended for mothers on azole antifungals OTHER than fluconazole (strong recommendation, moderate evidence), implicitly endorsing fluconazole as the acceptable azole during lactation 1. The American Academy of Pediatrics has indicated that breastfeeding while receiving fluconazole is likely safe for the newborn 1.

FDA Drug Label Information

The FDA label for Diflucan provides reassuring pharmacokinetic data 2:

• After a single 150 mg dose, the estimated daily infant dose from breast milk is 0.39 mg/kg/day, which represents only 13% of the recommended pediatric maintenance dose (3 mg/kg/day) 2
• A published survey of 96 breastfeeding women treated with fluconazole 150 mg every other day (average 7.3 capsules, range 1-29) for lactation-associated breast candidiasis reported no serious adverse reactions in infants 2
• The label advises that "caution should be exercised" but does not contraindicate breastfeeding 2

Clinical Context and Dosing Considerations

Standard Dosing for Breast/Nipple Candidiasis

Research demonstrates that most breastfeeding women with breast and nipple candidiasis require multiple doses of fluconazole 3:

• Women typically need 6 or fewer 150 mg capsules (median = 6, mean = 7.3) 3
• Only minor side effects were reported in nursing infants 3
• No need to interrupt breastfeeding during treatment 4

Important Caveats

The diagnosis of "mammary candidiasis" is frequently overdiagnosed, and there is limited evidence that Candida species actually cause the breast and nipple pain commonly attributed to them 5. A 2021 review found:

• Little evidence supports the hypothesis that Candida causes symptoms diagnosed as mammary candidiasis 5
• Antifungal treatments may not be more effective than time alone 5
• Unnecessary antifungal use disrupts protective microbiome homeostasis and contributes to antifungal resistance 5

Therefore, while fluconazole is safe during breastfeeding, ensure the diagnosis truly warrants antifungal therapy before prescribing 5.

Pregnancy vs. Breastfeeding Safety Profile

It's critical to distinguish fluconazole's safety profile in breastfeeding from pregnancy 1:

• During first trimester pregnancy: Fluconazole should be avoided due to teratogenic risk with doses ≥400 mg/day (craniosynostosis, skeletal abnormalities) 1
• During breastfeeding: Fluconazole is compatible and safe 1

Practical Recommendations

• Continue breastfeeding without interruption during fluconazole therapy 4
• Standard dosing (150 mg single dose or multiple doses as needed) is appropriate 2, 3
• Monitor the infant for any unusual symptoms, though serious adverse reactions are not expected 2
• Verify the diagnosis before initiating treatment, as mammary candidiasis is frequently overdiagnosed 5